Stem Cell Ophthalmology Treatment Study (SCOTS): Bone Marrow-Derived Stem Cells in the Treatment of Stargardt Disease

Stem Cell Ophthalmology Treatment Study (SCOTS): Bone Marrow-Derived Stem Cells in the Treatment of Stargardt Disease

<b>Background:</b> Stargardt Disease is the most common inherited macular degeneration, typically resulting in progressive central vision loss and legal blindness at an early age. We report regarding 34 eyes with Stargardt Disease treated in the Stem Cell Ophthalmology Treatment Study (S...

Full description

Bibliographic Details
Main Authors: Jeffrey N. Weiss, Steven Levy
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Medicines
Subjects:
Stargardt Disease
macular degeneration
SGDT1
bone marrow-derived stem cells
BMSC
stem cells
Online Access:https://www.mdpi.com/2305-6320/8/2/10

Internet

https://www.mdpi.com/2305-6320/8/2/10

Similar Items